TCBP Enters Research Planning Collaboration with Dr. Carlos Maluquer de Motes for Mpox TherapeuticPRNewsWire • 10/22/24
TCBP Announces Artificial Intelligence Initiative with Partner Carnegie Mellon University for Donor ScreeningPRNewsWire • 10/03/24
TCBP Announces First Patient Completed the Full Fose Regimen in ACHIEVE Clinical TrialPRNewsWire • 09/12/24
TCBP Announces Participation at the H.C. Wainwright 26th Annual Global Investment ConferencePRNewsWire • 09/05/24
TC BioPharm Announces Grant of European Patent Covering Use of Modified Gamma Delta Cells for the Treatment of Cancer and Viral IndicationsPRNewsWire • 08/28/24
TCBP Announces Dosing of 6th Patient in ACHIEVE Study in Patients with Acute Myeloid LeukemiaPRNewsWire • 07/22/24
TC BioPharm Announces Execution of Second Non-Binding Letter of Intent for Acquisition, Targeting Innovative CAR-T TherapiesPRNewsWire • 05/06/24
TCBP Announces Execution of Non-Binding Letter of Intent for Acquisition of NK Platform TechnologiesPRNewsWire • 04/04/24